| Product Code: ETC9961567 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Cachexia Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Cachexia Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Cachexia Treatment Market - Industry Life Cycle |
3.4 United States (US) Cachexia Treatment Market - Porter's Five Forces |
3.5 United States (US) Cachexia Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 United States (US) Cachexia Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United States (US) Cachexia Treatment Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 United States (US) Cachexia Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Cachexia Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United States (US) Cachexia Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Cachexia Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cachexia in the United States |
4.2.2 Growing awareness about the importance of treating cachexia |
4.2.3 Advances in medical research leading to new treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with cachexia treatment |
4.3.2 Limited reimbursement options for cachexia therapies |
4.3.3 Lack of standardized treatment guidelines for cachexia |
5 United States (US) Cachexia Treatment Market Trends |
6 United States (US) Cachexia Treatment Market, By Types |
6.1 United States (US) Cachexia Treatment Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Cachexia Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 United States (US) Cachexia Treatment Market Revenues & Volume, By Dronabinol, 2021- 2031F |
6.1.4 United States (US) Cachexia Treatment Market Revenues & Volume, By Mega Sterol Acetate, 2021- 2031F |
6.1.5 United States (US) Cachexia Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2 United States (US) Cachexia Treatment Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Cachexia Treatment Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 United States (US) Cachexia Treatment Market Revenues & Volume, By Congestive Heart Failure (CHF), 2021- 2031F |
6.2.4 United States (US) Cachexia Treatment Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.5 United States (US) Cachexia Treatment Market Revenues & Volume, By Chronic Kidney Disease, 2021- 2031F |
6.2.6 United States (US) Cachexia Treatment Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 United States (US) Cachexia Treatment Market Revenues & Volume, By Chronic Obstructive Pulmonary disease (COPD), 2021- 2031F |
6.3 United States (US) Cachexia Treatment Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Cachexia Treatment Market Revenues & Volume, By Tablets, 2021- 2031F |
6.3.3 United States (US) Cachexia Treatment Market Revenues & Volume, By Injections, 2021- 2031F |
6.3.4 United States (US) Cachexia Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Cachexia Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Cachexia Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Cachexia Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5 United States (US) Cachexia Treatment Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Cachexia Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Cachexia Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United States (US) Cachexia Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 United States (US) Cachexia Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Cachexia Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Cachexia Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Cachexia Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Cachexia Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 United States (US) Cachexia Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Cachexia Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Cachexia Treatment Market Export to Major Countries |
7.2 United States (US) Cachexia Treatment Market Imports from Major Countries |
8 United States (US) Cachexia Treatment Market Key Performance Indicators |
8.1 Patient adherence rates to cachexia treatment regimens |
8.2 Number of clinical trials investigating new cachexia treatments |
8.3 Adoption rate of innovative therapies for cachexia |
9 United States (US) Cachexia Treatment Market - Opportunity Assessment |
9.1 United States (US) Cachexia Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 United States (US) Cachexia Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United States (US) Cachexia Treatment Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 United States (US) Cachexia Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Cachexia Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United States (US) Cachexia Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Cachexia Treatment Market - Competitive Landscape |
10.1 United States (US) Cachexia Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Cachexia Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here